Activin A in JEG-3 cells: Potential role as an autocrine regulator of steroidogenesis in humans

Biology of Reproduction

Volumn 62, Issue 5, 2000, Pages 1224-1230

  Ni, Xueying ^a   Luo, Shuang ^a   Minegishi, Takashi ^b   Peng, Chun ^a  

^a YORK UNIVERSITY   (Canada)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; ESTRADIOL; MESSENGER RNA; PROGESTERONE;

ARTICLE; CHORIOCARCINOMA; ESTROGEN SYNTHESIS; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNOBLOTTING; NORTHERN BLOTTING; PRIORITY JOURNAL; PROGESTERONE SYNTHESIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; STEROIDOGENESIS; TROPHOBLAST;

EID: 0034094313     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod62.5.1224     Document Type: Article

References (50)

1. Vale W, Rivier J, Vanghan J, McClintock R, Corrigan A, Woo W, Karr D, Spiess J. Purification and characterization of a FSH releasing protein from porcine ovarian follicular-fluid. Nature 1986; 321:776-779.
2. Ying SY. Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle stimulating hormone. Endocr Rev 1988; 9:267-293.
3. Ling N, Ueno N, Ying SY, Esch F, Shimasaki S, Hotta M, Cuevas P, Guillemin R. Inhibins and activins. Vitam Horm 1988; 44:1-6.
4. Vale W, Rivier C, Hsueh A, Campen C, Meunier H, Bicsak T, Vaughan J, Corrigan A, Bardin W, Sawchenko P, Yu J, Plotsky P, Spiess J, River J. Chemical and biological characterization of the inhibin family of protein hormone. Recent Prog Horm Res 1988; 44:1-34.
5. Mather JP, Moore A, Li RH. Activins, inhibins, and follistatins: further thought on a growing family of regulators. Proc Soc Exp Biol Med 1997; 201:1-15.
6. Findlay JK. An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis. Biol Reprod 1993; 48:15-23.
7. Moore A, Krummen LA, Mather JP. Inhibins, activins, their binding proteins and receptors: interactions underlying paracrine activity in the testis. Mol Cell Endocrinol 1994; 100:81-86.
8. Knight PG. Roles of inhibins, activins, and follistatin in the female reproductive system. Front Neuroendocrinol 1996; 17:476-509.
9. Qu J, Thomas K. Inhibin and activin production in human placenta. Endocr Rev 1995; 16:485-507.
10. Petraglia F. Inhibin, activin and follistatin in the human placenta - a new family of regulatory protein. Placenta 1997; 18:3-8.
11. Petraglia F, Vaughan J, Vale W. Inhibin and activin modulate the release of gonadotropin-releasing hormone, human chorionic gonadotropin, and progesterone from cultured human placental cells. Proc Natl Acad Sci U S A 1989; 86:5114-5117.
12. Qu J, Thomas K. Regulation of inhibin secretion in human placental cell culture by epidermal growth factor, transforming growth factors and activin. J Clin Endocrinol Metab 1993; 77:925-931.
13. Caniggia I, Lye SJ, Cross JC. Activin is a local regulator of human cytotrophoblast cell differentiation. Endocrinology 1997; 138:3976-3986.
14. r 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proc Natl Acad Sci USA 1987; 84:8282-8286.
15. Petraglia F, Gallinelli A, Grande A, Florio P, Ferrari S, Genazzani AR, Ling N, Depaolo LV. Local production and action of follistatin in human placenta. J Clin Endocrinol Metab 1994; 78:205-210.
16. Yokoyama Y, Nakamura T, Nakamura R, Irahara M, Aono T, Sugino H. Identification of activins and follistatin proteins in human follicular fluid and placenta. J Clin Endocrinol Metab 1995; 80:915-921.
17. Shimasaki S, Koga M, Esch F, Cooksey K, Mercado M, Koba A, Ueno N, Ying SY, Ling N, Guillemin R. Primary structure of the human follistatin precursor and its genomic organization. Proc Natl Acad Sci USA 1988; 85:4218-4222.
18. Alevizopoulos A, Mermod N. Transforming growth factor-β: the breaking open of a black box. Bioessays 1997; 19:581-591.
19. Mathews LS. Activin receptors and cellular signaling by the receptor serine kinase family. Endocr Rev 1994; 15:310-325.
20. Matzuk MM, Bradley A. Cloning of the human activin receptor cDNA reveals high evolutionary conservation. Biochim Biophys Acta 1992: 1130:105-108.
21. Hildén K, Tuuri T, Erämaa M, Ritvos O. Expression of type II activin receptor genes during differentiation of human K562 cells and cDNA cloning of the human type IIB activin receptor Blood 1994; 83:2163-2170.
22. Matsuzaki K, McKeehan WL. Novel serine-kinase receptor type 1. J Biol Chem 1993; 268:12719-12723.
23. Xu J, Matsuzaki K, McKeehan K, Wang F, Kan M, Mckeehan WL. Genomic structure and cloned cDNAs predict that four variants in the kinase domain of serine/threonine kinase receptors arise by alternative splicing and poly(A) addition. Proc Natl Acad Sci USA 1994; 91: 7957-7961.
24. ten Dijke P, Ichijo H, Franzen P, Schulz, P, Saras J, Toyoshima H, Heldin CH, Miyazono K. Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene 1993; 8:2879-2887.
25. Hu PP, Dalto MB, Wang XF. Molecular mechanisms of transforming growth factor-β signaling. Endocr Rev 1998; 19:348-363.
26. Chen Y, Lebrun JJ, Vale W. Regulation of transforming growth factor β and activin-induced transcription by mammalian Mad proteins. Proc Natl Acad Sci USA 1996; 93:12992-12997.
27. Baker JC, Harland RM. A novel mesoderm inducer. Madr2, functions in the activin signal transduction pathway. Genes Dev 1996; 10:1880-1889.
28. Zhang Y, Musci T, Derynck R. The tumor suppressor Smd4/DPC4 as a central mediator of Smad function. Curr Biol 1997; 7:270-276.
29. Shimizu A, Kato M, Nakao A, Imamura T, ten Dijke P, Helkin CH, Kawabata M, Shimada S, Miyazono K. Identification of receptors and Smad proteins involved in activin signaling in a human epidermal keratinocyte cell line. Genes Cells 1998; 3:125-134.
30. Ringler GE, Strauss JF. In vitro system for the study of human placental endocrine function. Endocr Rev 1990; 11:105-123.
31. Bahn RS, Worsham A, Speeg KV, Ascoli M, Rabin D. Characterization of steroid production in the cultured human choriocarcinoma cells. J Clin Endocrinol Metab 1981; 52:447-450.
32. Petraglia F, Gallinelli A, De Vita D, Lewis K, Mathews L, Vale W. Activin at parturition: change of maternal serum levels and evidence for binding sites in placenta and fetal membranes. Obstet Gynecol 1994; 84:278-282.
33. Peng C, Huang TH, Jeung FB, Donaldson CJ, Vale WW, Leung PC. Expression of the type II activin receptor gene in the human placenta. Endocrinology 1993; 133:3046-3049.
34. Murata M, Eto Y, Shibai H, Sakai M, Muramatsu M. Erythroid differentiation factor is encoded by the same mRNA as that of the inhibin β-A chain. Proc Natl Acad Sci U S A 1987; 85:2434-2438.
35. Peng C, Leung PC. Follistatin in human granulosa-luteal cells: gene expression and steroidogenic action. In: Li W, Chen H, Hahn DW (eds.), Fertility Regulation: Present and Future. Chapter 2. Bethesda, MD: National Institute of Health; 1997: 35-40.
36. Peng C, Ohno T, Koh LY, Chen V, Leung PC. Human ovary and placenta express messenger RNA for multiple activin receptors. Life Sci 1999; 64:983-994.
37. Winter JP, Dijke P, Vries CJ, Achterberg TA, Sugino H, Waele P, Huylebroeck D, Verschueren K, Eijnden-van Raaij AJ. Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors. Mol Cell Endocrinol 1996; 116:105-114.
38. Caestecker MP, Hemmati P, Larisch-Bloch S, Ajmera R, Roberts AB, Lechleider RJ. Characterization of functional domains within Smad4/ DPC4. J Biol Chem 1997; 272:13690-13696.
39. Takenoshita S, Mogi A, Nagashima M, Yang K, Yagi K, Hanyu A, Nagamachi Y, Miyazono K, Hagiwara K. Characterization of the MADH2/Smad2 gene, a human Mad homologue responsible for the transforming growth factor-β and activin signal transduction pathway. Genomics 1998 48:1-11.
40. Poncelet A-C, de Caestecker MP, Schnaper HW. The transforming growth factor-β/Smad signaling pathway is present and functional in human mesangial cells. Kidney Int 1999; 56:1354-1365.
41. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE. DEPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996; 271:350-353.
42. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui LC, Bapat B, Gallinger S, Andrulis IL, Thomsen GH, Wrana JL, Attisano L. MADR2 maps to 18q21 and encodes a TGF-β regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 1996; 86:543-552.
43. Riggins GJ, Thiagalingam S, Rozenblum E, Weinstein CL, Kern SE, Hamilton SR, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B. Mad-related genes in the human. Nat Genet 1996; 13:347-349.
44. Song Y, Keelan J, France JT. Activin-A stimulates, while transforming growth factor-β1 inhibits, chorionic gonadotropin production and aromatase activity in cultured human placenta trophoblasts. Placenta 1996; 17:603-610.
45. Phillips DJ, de Kretser DM. Follistatin: a multifunctional regulatory proteins. Front Neuroendocrinol 1998; 19:287-322.
46. Hushimoto O, Nakamura T, Shoji H, Shimasaki S, Hayashi Y, Sugino H. A novel role of follistatin, an activin binding protein, in the inhibition of activin action in rat pituitary cells. Endocytotic degradation of activin and its acceleration by follistatin associated with cell surface heparan sulfate. J Biol Chem 1997; 272:13835-13842.
47. Gonzalez-Manchon C, Vale W. Activin A, inhibin and TGF-β modulate growth of two gonadal cell lines. Endocrinology 1989; 125: 1666-1672.
48. McPherson SJ, Thomas TZ, Wang H, Gurusinghe CI, Risbridger GP. Growth inhibitory response to activin A and B by human prostate tumor cell lines. LNCap and DU145. J Endocrinol 1997; 154:535-545.
49. McCarthy SA, Bicknell R. Inhibition of vascular endothelial cell growth by activin-A. J Biol Chem 1993; 268:23066-23071.
50. Miro F, Hiller SG. Modulation of granulosa cell deoxyribonucleic acid synthesis and differentiation by activin. Endocrinology 1996; 137: 464-468.